Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS)

Clinical trial NCT01005628 · COMPLETED

Trial details

NCT number: NCT01005628
Sponsor: Janssen Korea, Ltd., Korea
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2006-06-01
Primary completion: 2012-03-01
Enrollment: 1121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.